Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Colorectal Neoplasms

Free Subscription 21.12.2020 2 Am J Surg 2 Ann Oncol 2 Ann Surg 4 Anticancer Res 5 BMC Cancer 1 Br J Cancer 11 Br J Surg 3 Cancer Lett 2 Clin Cancer Res 18 Dis Colon Rectum 3 Eur J Cancer 11 Eur J Surg Oncol 3 Gastroenterology 1 Gut 4 Int J Cancer 10 Int J Colorectal Dis 1 J Am Coll Surg 1 J Surg Oncol 1 N Engl J Med 2 Nat Rev Cancer 3 Oncogene 1 Oncol Rep 1 Oncology 10 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. KOCH KE, Goffredo P, Hrabe JE, Gribovskaja-Rupp I, et al
   Impact of routine mismatch repair screening on genetic counseling and surgical management in colorectal cancer patients.
   Am J Surg. 2020 Dec 9. pii: S0002-9610(20)30795.
   PubMed         Abstract available
   
   
2. LANGENFELD SJ
   Invited commentary (The effect of pre-operative diagnosis on patient reported outcomes in patients undergoing colorectal operations: A prospective study).
   Am J Surg. 2020;220:1387.
   PubMed        
   
   

   
   Ann Oncol

3. JONES H, Gilbert D, Gilbert A, Jacobs C, et al
   DPD testing in radical chemoradiation for anal squamous cell carcinoma.
   Ann Oncol. 2020;31:1580.
   PubMed        
   
   
4. GLYNNE-JONES R, Meadows HM, Lopes A, Muirhead R, et al
   Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs.
   Ann Oncol. 2020;31:1587-1588.
   PubMed        
   
   

   
   Ann Surg

5. DENG X, Liu P, Jiang D, Wei M, et al
   Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
   Ann Surg. 2020;272:1060-1069.
   PubMed         Abstract available
   
   
6. YAMASHITA S, Chun YS, Kopetz SE, Maru D, et al
   APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
   Ann Surg. 2020;272:1080-1085.
   PubMed         Abstract available
   
   

   
   Anticancer Res

7. YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
   A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
   Anticancer Res. 2020;40:6765-6768.
   PubMed         Abstract available
   
   
8. ANNICCHIARICO A, Morini A, Romboli A, RiccO M, et al
   Stage III and Metastatic Lymph Node Ratio Are the only Independent Prognostic Factors in Colorectal Signet-ring Cell Carcinoma Patients.
   Anticancer Res. 2020;40:7127-7134.
   PubMed         Abstract available
   
   
9. LIU B, Shiraga S, Mortenson MM, Lai J, et al
   Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
   Anticancer Res. 2020;40:7053-7056.
   PubMed         Abstract available
   
   
10. VODICKA J, Fichtl J, Sebek J, ProchAzkovA K, et al
    Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma.
    Anticancer Res. 2020;40:7045-7051.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. WATANABE K, Katayama K, Yoshioka T, Narimatsu H, et al
    Impact of individual background on the unmet needs of cancer survivors and caregivers - a mixed-methods analysis.
    BMC Cancer. 2020;20:263.
    PubMed         Abstract available
    
    
12. MUKUND K, Syulyukina N, Ramamoorthy S, Subramaniam S, et al
    Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
    BMC Cancer. 2020;20:317.
    PubMed         Abstract available
    
    
13. NAKAJIMA T, Uehara T, Iwaya M, Kobayashi Y, et al
    Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency.
    BMC Cancer. 2020;20:319.
    PubMed         Abstract available
    
    
14. LI X, Yu W, Liang C, Xu Y, et al
    INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    BMC Cancer. 2020;20:305.
    PubMed         Abstract available
    
    
15. CAI Z, Xie X, Chen Y, Chen Z, et al
    Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer.
    BMC Cancer. 2020;20:253.
    PubMed         Abstract available
    
    

    
    Br J Cancer

16. LOUGHREY MB, Fisher NC, McCooey AJ, Dunne PD, et al
    Comment on "Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes".
    Br J Cancer. 2020 Dec 14. pii: 10.1038/s41416-020-01213.
    PubMed        
    
    

    
    Br J Surg

17. TSUKAMOTO S, Fujita S, Ota M, Mizusawa J, et al
    Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Br J Surg. 2020;107:586-594.
    PubMed         Abstract available
    
    
18. SVANSTROM ROJVALL A, Buchli C, Bottai M, Ahlberg M, et al
    Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study.
    Br J Surg. 2020;107:525-536.
    PubMed        
    
    
19. KARACHUN A, Panaiotti L, Chernikovskiy I, Achkasov S, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:499-508.
    PubMed         Abstract available
    
    
20. GRASS F, Hubner M, Mathis KL, Hahnloser D, et al
    Identification of patients eligible for discharge within 48 h of colorectal resection.
    Br J Surg. 2020;107:546-551.
    PubMed         Abstract available
    
    
21. CRIPPA J, Grass F, Achilli P, Mathis KL, et al
    Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:560-566.
    PubMed         Abstract available
    
    
22. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    PubMed         Abstract available
    
    
23. AGGER EA, Jorgren FH, Lydrup MA, Buchwald PL, et al
    Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study.
    Br J Surg. 2020;107:580-585.
    PubMed         Abstract available
    
    
24. ZABOROWSKI AM, Murphy B, Creavin B, Rogers AC, et al
    Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:606-612.
    PubMed         Abstract available
    
    
25. NG KS, Russo R, Gladman MA
    Colonic transit in patients after anterior resection: prospective, comparative study using single-photon emission CT/CT scintigraphy.
    Br J Surg. 2020;107:567-579.
    PubMed         Abstract available
    
    
26. DENOST Q
    The challenge posed by young-onset rectal cancer.
    Br J Surg. 2020;107:481-483.
    PubMed        
    
    
27. VAN DER HEIJDEN JAG, Koeter T, Smits LJH, Sietses C, et al
    Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis.
    Br J Surg. 2020;107:489-498.
    PubMed         Abstract available
    
    

    
    Cancer Lett

28. SUI Q, Peng J, Han K, Lin J, et al
    Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
    Cancer Lett. 2020 Dec 15. pii: S0304-3835(20)30667.
    PubMed         Abstract available
    
    
29. TIAN H, Kang Y, Song X, Xu Y, et al
    PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses.
    Cancer Lett. 2020;476:170-182.
    PubMed         Abstract available
    
    
30. LU C, Klement JD, Yang D, Albers T, et al
    SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
    Cancer Lett. 2020;476:87-96.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

31. VAN CUTSEM E, Paccard C, Chiron M, Tabernero J, et al
    Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial.
    Clin Cancer Res. 2020;26:717-725.
    PubMed         Abstract available
    
    
32. HICKS KC, Knudson KM, Lee KL, Hamilton DH, et al
    Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy.
    Clin Cancer Res. 2020;26:704-716.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

33. PEREZ RO
    Expert Commentary on Organ Preservation in the Treatment of Stage II and III Rectal Cancer.
    Dis Colon Rectum. 2020;63:1189-1190.
    PubMed        
    
    
34. FERNANDES JM, Jandrey EHF, Koyama FC, Leite KRM, et al
    Metformin as an Alternative Radiosensitizing Agent to 5-Fluorouracil During Neoadjuvant Treatment for Rectal Cancer.
    Dis Colon Rectum. 2020;63:918-926.
    PubMed         Abstract available
    
    
35. FOLEY KE, Izquierdo KM, von Muchow MG, Bastawrous AL, et al
    Colon and Rectal Surgery Robotic Training Programs: An Evaluation of Gender Disparities.
    Dis Colon Rectum. 2020;63:974-979.
    PubMed         Abstract available
    
    
36. QUEZADA-DIAZ FF, Smith JJ, Jimenez-Rodriguez RM, Wasserman I, et al
    Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study.
    Dis Colon Rectum. 2020;63:897-902.
    PubMed         Abstract available
    
    
37. LIU Y, Sigel KM, Westra W, Gitman MR, et al
    HIV-Infected Patients With Anal Cancer Precursors: Clinicopathological Characteristics and Human Papillomavirus Subtype Distribution.
    Dis Colon Rectum. 2020;63:890-896.
    PubMed         Abstract available
    
    
38. CHITTLEBOROUGH TJ, Gutlic I, Pearson JF, Watson A, et al
    Increasing Incidence of Young-Onset Colorectal Carcinoma A 3-Country Population Analysis.
    Dis Colon Rectum. 2020;63:903-910.
    PubMed         Abstract available
    
    
39. ECKBERG SE, Dahlberg MJA, der Hagopian OS, Farahnak P, et al
    Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
    Dis Colon Rectum. 2020 Dec 2. doi: 10.1097/DCR.0000000000001746.
    PubMed         Abstract available
    
    
40. HAJIBANDEH S, Hajibandeh S, Maw A
    Meta-analysis and Trial Sequential Analysis of Randomized Controlled Trials Comparing High and Low Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery.
    Dis Colon Rectum. 2020;63:988-999.
    PubMed         Abstract available
    
    
41. DE BUCK VAN OVERSTRAETEN A, Khorasani S, Kennedy E, Look Hong NJ, et al
    Nonoperative Management Versus Radical Surgery of Rectal Cancer After Neoadjuvant Therapy-Induced Clinical Complete Response: A Markov Decision Analysis.
    Dis Colon Rectum. 2020;63:1080-1089.
    PubMed         Abstract available
    
    
42. MUKKAMALA A, Montgomery JR, De Roo AC, Ogilvie JW Jr, et al
    Population-Based Analysis of Adherence to Postdischarge Extended Venous Thromboembolism Prophylaxis After Colorectal Resection.
    Dis Colon Rectum. 2020;63:911-917.
    PubMed         Abstract available
    
    
43. MUTHUKURU S, Alomari M, Bisen R, Parikh MP, et al
    Quality of Colonoscopy: A Comparison Between Gastroenterologists and Nongastroenterologists.
    Dis Colon Rectum. 2020;63:980-987.
    PubMed         Abstract available
    
    
44. KREZALEK MA, Contreras-Peraza N, Parker ME, Kelley SR, et al
    Hybrid Robotic Transanal Minimally Invasive Surgery Approach to Large and Low-Lying Rectal Polyps.
    Dis Colon Rectum. 2020;63:1001-1006.
    PubMed         Abstract available
    
    
45. FERNANDEZ LM, Figueiredo NL, Habr-Gama A, Sao Juliao GP, et al
    Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
    Dis Colon Rectum. 2020;63:1053-1062.
    PubMed         Abstract available
    
    
46. SHO S, Yothers G, Colangelo LH, Ganz PA, et al
    Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG Oncology.
    Dis Colon Rectum. 2020;63:1063-1070.
    PubMed         Abstract available
    
    
47. CHANG SC, Chen HC, Chen YC, Ke TW, et al
    Long-term Oncologic Outcomes of Laparoscopic Anterior Resections for Cancer with Natural Orifice Versus Conventional Specimen Extraction: A Case-Control Study.
    Dis Colon Rectum. 2020;63:1071-1079.
    PubMed         Abstract available
    
    
48. HAN JG, Wang ZJ
    The Authors Reply.
    Dis Colon Rectum. 2020;63:e497.
    PubMed        
    
    
49. YANG T, Shen Y, Wang Z
    Perineal Wound Complications After Extralevator Abdominoperineal Excision for Low Rectal Cancer: A Call to Introduce a Standard Definition and Classification.
    Dis Colon Rectum. 2020;63:e496.
    PubMed        
    
    
50. FRANCONE TD
    Robotic Right Colectomy With Intracorporeal Anastomosis.
    Dis Colon Rectum. 2020;63:e486.
    PubMed        
    
    

    
    Eur J Cancer

51. COLLE R, Radzik A, Cohen R, Pellat A, et al
    Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
    Eur J Cancer. 2020;144:9-16.
    PubMed         Abstract available
    
    
52. MANCA P, Corallo S, Randon G, Lonardi S, et al
    Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer.
    Eur J Cancer. 2020;144:31-40.
    PubMed         Abstract available
    
    
53. NAKAYAMA G, Takano N, Taniguchi H, Ishigure K, et al
    Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study).
    Eur J Cancer. 2020;144:61-71.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

54. DI FRANCO G, Gianardi D, Palmeri M, Furbetta N, et al
    Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.
    Eur J Surg Oncol. 2020;46:825-831.
    PubMed         Abstract available
    
    
55. PROCOPIO F, Vigano L, Cimino M, Donadon M, et al
    Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
    Eur J Surg Oncol. 2020;46:818-824.
    PubMed         Abstract available
    
    
56. DI MARTINO M, Rompianesi G, Mora-Guzman I, Martin-Perez E, et al
    Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Eur J Surg Oncol. 2020;46:772-781.
    PubMed         Abstract available
    
    
57. BARATTI D, Sammartino P, Kusamura S, Deraco M, et al
    Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.
    Eur J Surg Oncol. 2020;46:737-739.
    PubMed        
    
    
58. WANG X, Chen G, Zhang Y, Ghareeb WM, et al
    The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Eur J Surg Oncol. 2020;46:1118-1123.
    PubMed         Abstract available
    
    
59. VUTHALURU S, Jain M, Seenu V
    Letter to Editor- Minimally invasive surgery for T4 colon cancer is associated with better outcomes than open surgery in National Cancer Database.
    Eur J Surg Oncol. 2020 Dec 5. pii: S0748-7983(20)31038.
    PubMed        
    
    
60. CYR DP, Zih FS, Wells BJ, Swett-Cosentino J, et al
    Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study.
    Eur J Surg Oncol. 2020;46:1131-1137.
    PubMed         Abstract available
    
    
61. LORENZON L, Polom K
    Reply to: Tumour Biology and lack of standardization in assessment of ypT0 has an impact on survival in patients with locally advanced rectal cancers achieving complete pathological response after neoadjuvant chemoradiation.
    Eur J Surg Oncol. 2020;46:1562-1563.
    PubMed        
    
    
62. REN L, Zhu D, Benson AB 3rd, Nordlinger B, et al
    Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).
    Eur J Surg Oncol. 2020;46:955-966.
    PubMed         Abstract available
    
    
63. KOMMALAPATI A, Tella SH, Yadav S, Goyal G, et al
    Survival and prognostic factors in patients with rectal squamous cell carcinoma.
    Eur J Surg Oncol. 2020;46:1111-1117.
    PubMed         Abstract available
    
    
64. HAGEMANS JAW, Voogt ELK, Rothbarth J, Nieuwenhuijzen GAP, et al
    Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
    Eur J Surg Oncol. 2020;46:1160-1166.
    PubMed         Abstract available
    
    

    
    Gastroenterology

65. SIMMER F, van der Linden R, Ligtenberg MJ, Ylstra B, et al
    Multifocal colorectal cancer - Do intraluminal metastases occur?
    Gastroenterology. 2020 Dec 11. pii: S0016-5085(20)35544.
    PubMed        
    
    
66. JOSEPH A, Roper J
    Genetic evidence that a gut commensal bacterium can cause colorectal cancer.
    Gastroenterology. 2020 Dec 10. pii: S0016-5085(20)35549.
    PubMed         Abstract available
    
    
67. STANICH PP, Pelstring KR, Hampel H, Pearlman R, et al
    A High Percentage of Early-Age Onset Colorectal Cancer is Potentially Preventable.
    Gastroenterology. 2020 Dec 10. pii: S0016-5085(20)35543.
    PubMed        
    
    

    
    Gut

68. HONG J, Guo F, Lu SY, Shen C, et al
    F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.
    Gut. 2020 Dec 14. pii: gutjnl-2020-322780. doi: 10.1136/gutjnl-2020-322780.
    PubMed         Abstract available
    
    

    
    Int J Cancer

69. ORNTOFT MW, Jensen SO, Ogaard N, Henriksen TV, et al
    Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33434.
    PubMed         Abstract available
    
    
70. HEISSER T, Hoffmeister M, Brenner H
    Effects of Screening for Colorectal Cancer: Development, Documentation and Validation of a Multistate Markov Model.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33437.
    PubMed         Abstract available
    
    
71. JENSEN BV, Schou JV, Yilmaz M, Johannesen HH, et al
    Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.
    Int J Cancer. 2020 Dec 17. doi: 10.1002/ijc.33448.
    PubMed         Abstract available
    
    
72. LONG L, Yang W, Liu L, Tobias DK, et al
    Dietary intake of branched-chain amino acids and survival after colorectal cancer diagnosis.
    Int J Cancer. 2020 Dec 19. doi: 10.1002/ijc.33449.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

73. COHEN R, Platell C
    Primary local excision of stage 1 rectal cancer is not associated with worse oncological outcomes when compared with major resection.
    Int J Colorectal Dis. 2020;35:607-614.
    PubMed         Abstract available
    
    
74. RICKENBACHER A, Watson J, Horisberger K, Topfer A, et al
    Direct intraoperative assessment of total mesorectal excision specimens by expert pathologists in patients with very low rectal cancer prevents unnecessary abdominoperineal resections.
    Int J Colorectal Dis. 2020;35:755-758.
    PubMed         Abstract available
    
    
75. TAMINI N, Ceresoli M, Alde S, Carissimi F, et al
    Quasi-elective left colectomy after endoscopic colon stenting for obstructive cancer yields comparable oncologic outcome to full-elective operation.
    Int J Colorectal Dis. 2020;35:633-640.
    PubMed         Abstract available
    
    
76. SHIRATORI H, Nozawa H, Kawai K, Hata K, et al
    Risk factors and therapeutic significance of inguinal lymph node metastasis in advanced lower rectal cancer.
    Int J Colorectal Dis. 2020;35:655-664.
    PubMed         Abstract available
    
    
77. TONG L, Xie D, Song X, Wu X, et al
    Is abdominal vascular calcification score valuable in predicting the occurrence of colorectal anastomotic leakage? A meta-analysis.
    Int J Colorectal Dis. 2020;35:641-653.
    PubMed         Abstract available
    
    
78. BABAYA A, Yamano T, Matsubara T, Takenaka Y, et al
    Long-term clinical outcomes and follow-up status in Japanese patients with familial adenomatous polyposis after radical surgery: a descriptive, retrospective cohort study from a single institute.
    Int J Colorectal Dis. 2020;35:675-684.
    PubMed         Abstract available
    
    
79. DELL'ACQUA V, Surgo A, Arculeo S, Zerella MA, et al
    Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
    Int J Colorectal Dis. 2020;35:685-694.
    PubMed         Abstract available
    
    
80. HUANG Z, Wang X, Zou Q, Zhuang Z, et al
    High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer.
    Int J Colorectal Dis. 2020;35:695-704.
    PubMed         Abstract available
    
    
81. HAJIBANDEH S, Hajibandeh S, Eltair M, George AT, et al
    Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.
    Int J Colorectal Dis. 2020;35:575-593.
    PubMed         Abstract available
    
    
82. VERA R, Mata E, Gonzalez E, Juez I, et al
    Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
    Int J Colorectal Dis. 2020;35:739-746.
    PubMed         Abstract available
    
    

    
    J Am Coll Surg

83. QUEZADA-DIAZ FF, Hameed I, von Mueffling A, Salo-Mullen EE, et al
    Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
    J Am Coll Surg. 2020;230:669-675.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

84. HAMID HKS
    Considerations for transanal surgery during COVID-19 pandemic.
    J Surg Oncol. 2020;122:995.
    PubMed        
    
    

    
    N Engl J Med

85. LU KH, Broaddus RR
    Endometrial Cancer.
    N Engl J Med. 2020;383:2053-2064.
    PubMed        
    
    

    
    Nat Rev Cancer

86. BRUNI D, Angell HK, Galon J
    The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Nat Rev Cancer. 2020;20:662-680.
    PubMed         Abstract available
    
    
87. SETON-ROGERS S
    Compartmental reorganization suppresses tumours.
    Nat Rev Cancer. 2020;20:625.
    PubMed        
    
    

    
    Oncogene

88. BERGIN CJ, Zouggar A, Haebe JR, Masibag AN, et al
    G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01591.
    PubMed         Abstract available
    
    
89. XU H, Liu L, Li W, Zou D, et al
    Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01587.
    PubMed         Abstract available
    
    
90. XU L, Huan L, Guo T, Wu Y, et al
    LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1alpha.
    Oncogene. 2020;39:7005-7018.
    PubMed         Abstract available
    
    

    
    Oncol Rep

91. YASSIN S, Hu J, Xu H, Li C, et al
    [Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT116 xenograft model in nude mice.
    Oncol Rep. 2020;43:1349.
    PubMed         Abstract available
    
    

    
    Oncology

92. MIYAKITA H, Sadahiro S, Suzuki T, Chan LF, et al
    Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
    Oncology. 2020;98:869-875.
    PubMed         Abstract available
    
    

    
    PLoS One

93. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    PubMed         Abstract available
    
    
94. HUANG CW, Su WC, Yin TC, Chen PJ, et al
    Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy.
    PLoS One. 2020;15:e0240742.
    PubMed         Abstract available
    
    
95. HARDCASTLE SJ, Jimenez-Castuera R, Maxwell-Smith C, Bulsara MK, et al
    Fitbit wear-time and patterns of activity in cancer survivors throughout a physical activity intervention and follow-up: Exploratory analysis from a randomised controlled trial.
    PLoS One. 2020;15:e0240967.
    PubMed         Abstract available
    
    
96. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    PubMed         Abstract available
    
    
97. LUO P, Wu S, Ji K, Yuan X, et al
    LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.
    PLoS One. 2020;15:e0223035.
    PubMed         Abstract available
    
    
98. ANDREU-BALLESTER JC, Galindo-Regal L, Hidalgo-Coloma J, Cuellar C, et al
    Differences in circulating gammadelta T cells in patients with primary colon cancer and relation with prognostic factors.
    PLoS One. 2020;15:e0243545.
    PubMed         Abstract available
    
    
99. ARNADOTTIR SS, Mattesen TB, Vang S, Madsen MR, et al
    Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    PLoS One. 2020;15:e0241148.
    PubMed         Abstract available
    
    
100. 
     Retraction: Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer.
     PLoS One. 2020;15:e0244280.
     PubMed        
     
     
101. 
     Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.
     PLoS One. 2020;15:e0244268.
     PubMed        
     
     
102. HONG TC, Yang HC, Chen CL, Kao JH, et al
     Relationship between serum gamma-glutamyl transferase level and colorectal adenoma.
     PLoS One. 2020;15:e0240445.
     PubMed         Abstract available
     
     

     
     World J Surg

103. BUISMAN FE, Galjart B, van der Stok EP, Balachandran VP, et al
     Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy.
     World J Surg. 2020;44:876-886.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: